OPTIMAL COMBINATION OF IMMUNOSUPPRESSIVE AGENTS FOR RENAL-TRANSPLANTATION - THE AUSTRALIAN TRIAL COMPARING CYCLOSPORINE (C) PLUS PREDNISOLONE (P) WITH C PLUS AZATHIOPRINE (A) AND C+A+P

被引：0
|
作者：
HARDIE, I [1 ]
TILLER, D [1 ]
MAHONY, J [1 ]
MIACH, P [1 ]
THOMSON, N [1 ]
THATCHER, G [1 ]
RIGBY, R [1 ]
MENZIES, B [1 ]
机构：
[1] PRINCESS ALEXANDRA HOSP,DEPT SURG,AUSTRALIAN COLLABORAT TRIALS COMM,BRISBANE,QLD 4102,AUSTRALIA
来源：
KIDNEY INTERNATIONAL | 1994年 / 45卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1264 / 1265
页数：2
相关论文
共 50 条
  • [1] 1ST REPORT OF AN AUSTRALIAN RANDOMIZED TRIAL COMPARING CYCLOSPORINE PLUS PREDNISOLONE WITH CYCLOSPORINE PLUS AZATHIOPRINE AND CYCLOSPORINE PLUS AZATHIOPRINE PLUS PREDNISOLONE IN RENAL-TRANSPLANTATION
    HARDIE, IR
    TILLER, DJ
    MAHONY, JF
    MIACH, PJ
    THOMSON, NM
    THATCHER, GN
    RIGBY, RJ
    MENZIES, BL
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (05) : 2241 - 2242
  • [2] OPTIMAL COMBINATION OF IMMUNOSUPPRESSIVE AGENTS FOR RENAL-TRANSPLANTATION - 1ST REPORT OF A MULTICENTER, RANDOMIZED TRIAL COMPARING CYCLOSPORINE+ PREDNISOLONE WITH CYCLOSPORINE+ AZATHIOPRINE AND WITH TRIPLE THERAPY IN CADAVER RENAL-TRANSPLANTATION
    HARDIE, IR
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 583 - 584
  • [3] PROTEIN-C AFTER RENAL-TRANSPLANTATION WITH CYCLOSPORINE OR AZATHIOPRINE TREATMENT
    SEYFERT, UT
    ALBERT, FW
    KRAMER, W
    BUHLER, G
    SCHMIDT, U
    UHRIG, M
    HAEMOSTASIS, 1985, 15 (01) : 48 - 48
  • [4] IMMUNOSUPPRESSIVE EFFICACY OF LOW-DOSES OF CYCLOSPORINE (CI), AZATHIOPRINE (AZA) AND PREDNISONE (P) IN RENAL-TRANSPLANTATION
    PALLARDO, L
    SANCHEZ, J
    GARCIA, J
    CALVO, C
    ANTONIO, P
    MORENO, R
    CRUZ, JM
    KIDNEY INTERNATIONAL, 1987, 32 (04) : 610 - 611
  • [5] THE USE OF CYCLOSPORINE (C) ONLY IN CADAVERIC RENAL-TRANSPLANT RECIPIENTS (CRTR) - CONVERSION TO PREDNISOLONE (P) AND AZATHIOPRINE (A) AFTER 4 MONTHS
    TEGZESS, AM
    DONKER, AJM
    MEIJER, S
    VANSON, WJ
    VANDERWOUDE, FJ
    SLOOFF, MJH
    VANDERSLIKKE, LB
    KIDNEY INTERNATIONAL, 1984, 26 (04) : 656 - 656
  • [6] Phase 2 neoadjuvant trial: myocet (M), cyclophosphamide (C) plus /- trastuzumab (T) and paclitaxel (P) plus /-T
    Pistilli, B.
    Benedetti, G.
    Rossi, D.
    Baldelli, A. M.
    Magalotti, C.
    Casadei, V.
    Foghini, L.
    Staffolani, M.
    Fiorentini, G.
    Latini, L.
    BREAST, 2015, 24 : S98 - S98
  • [7] A RANDOMIZED PHASE II CLINICAL TRIAL OF THE SRC INHIBITOR SARACATINIB (AZD0530) AND CARBOPLATIN plus PACLITAXEL (C plus P) VERSUS C plus P IN PATIENTS (PTS) WITH ADVANCED PLATINUM-SENSITIVE EPITHELIAL OVARIAN CANCER (EOC)
    Poole, C.
    Lisyanskaya, A.
    Rodenhuis, S.
    Kristensen, G.
    Lauraine, E. Pujade
    Cantarini, M.
    Emeribe, U.
    Stuart, M.
    Coquard, I. Ray
    ANNALS OF ONCOLOGY, 2010, 21 : 304 - 305
  • [8] Randomized, multicenter trial comparing tacrolimus plus mycophenolate mofetil to tacrolimus plus steroids in hepatitis C virus-positive recipients of living donor liver transplantation
    Takada, Yasutsugu
    Kaido, Toshimi
    Asonuma, Katsuhiro
    Sakurai, Hiroyuki
    Kubo, Shoji
    Kiuchi, Tetsuya
    Inomata, Yukihiro
    Isaji, Shuji
    Tsumura, Hayami
    Teramukai, Satoshi
    Matsubara, Yoshihiro
    Sakabayashi, Satomi
    Uemoto, Shinji
    LIVER TRANSPLANTATION, 2013, 19 (08) : 896 - 906
  • [9] Results of a phase Ib study of ARQ 092 in combination with carboplatin (C) plus paclitaxel (P), or with P in patients (pts) with solid tumors.
    Lakhani, Nehal
    Tolcher, Anthony W.
    Rasco, Drew W.
    Patnaik, Amita
    O'Rourke, Timothy J.
    Schwartz, Brian E.
    Abbadessa, Giovanni
    Kazakin, Julia
    Savage, Ronald
    Wang, Yunxia
    Chai, Feng
    Papadopoulos, Kyriakos P.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Comparison of outcomes with pembrolizumab monotherapy (P) versus combination with chemotherapy (P plus C) in advanced non-small cell lung cancer (NSCLC).
    Sehgal, Kartik
    Gill, Ritu R.
    Bindal, Poorva
    Koshy, Anita Geevarghese
    McDonald, Danielle C.
    Rangachari, Deepa
    Costa, Daniel Botelho
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345